Patients and Victims

GS-II: Patients and Victims

Context

Last year, a series of reports revealed the traumatic experiences of Indian patients who had received faulty hip implants manufactured by the pharma major, Johnson and Johnson

Another investigation has revealed that Johnson and Johnson paid hefty compensations to US patients who had received the defective implants.

In India, however, the company has challenged government orders to compensate 4,700 patients who had undergone hip replacement surgeries.

Background

The investigations pertain to implants manufactured under two brand names, ASR and Pinnacle.
Both products are not in the market currently.
Johnson and Johnson recalled ASR from the global market in 2010, while Pinnacle was withdrawn in 2013.

The slow reaction by India

In India, in contrast, regulators were slow to react.
Maharashtra’s FDA red-flagged ASR a few months after Johnson and Johnson withdrew the product from the global market.
It took another year for the Central Drugs Standard Control Organisation to ban the import of ASR.
Another year went by before the drug regulator issued an advisory to orthopaedic surgeons asking them to not implant ASR.
These delays are significant because last year, Johnson and Johnson told a Union Ministry of Health and Family Welfare (MoHFW) expert committee that it cannot trace as many as 3,600 patients who underwent surgeries involving the faulty implant.
That India did not have a joint registry when these surgeries happened has compounded the problem.
The want of a registry has also come in the way of ascertaining the damage caused by Pinnacle. Johnson and Johnson claims that it has no adverse reports of the device in the country.

Conclusion

In 2017, the MoHFW issued the Medical Devices Rules. However, the country’s base legislation on implants continues to be the Drugs and Cosmetics Act, 1940, which does not have the scope to cover most modern devices, including hip implants. The Indian orthopaedic device market is valued at over 450 million dollars and is expected to grow by 30 per cent per year till 2025.The investigations into faulty hip implants bring out the urgent need for a law to regulate medical devices.

Source: Indian Express

Join Our Telegram

Breast milk banks to ensure all infants get protective cover

Rupee Matters

Pradhan Mantri Suryodaya Yojana

06 Feb, 24
SHARE

Recently, Prime Minister announced Pradhan Mantri Suryodaya Yojana under which 1 crore households will get rooftop solar power systems. India’s Status of Current Solar Capacity India currently stands at 4th place globally in solar power capacity. As per Ministry of New an

Foreign Contribution Regulation Act (FCRA)- NGO

06 Feb, 24
SHARE

The Foreign Contribution Regulation Act, 2010 (FCRA) registration of two prominent non-governmental organisations (NGOs) — Centre for Policy Research (CPR) and World Vision India (WVI) have been cancelled this month. What is FCRA? Key provisions of FCRA, 2010 Key aspects Description

Voice clone-AI

06 Feb, 24
SHARE

Voice clone fraud has been on the rise in India. AI voice cloning – It is the process of creating a synthetic replica of a person’s voice through machine learning and speech synthesis technology.It is called as voice deepfakesor audio deepfakes. Objective – To achieve a high level of na

Science communication- how to promote

06 Feb, 24
SHARE

Steps taken by India to promote Science Communication Publications and Information Directorate (PID) - An organisation under Council of Science and Industrial Research (CSIR) established in 1951 for publishing and disseminating scientific information in India. National science magazines- The PI

Universal Basic Income (UBI)- Analysis

05 Feb, 24
SHARE

Universal Basic Income (UBI) can strengthen welfare architecture and unlock the nation’s latent demographic potential. UBI - It is an income support mechanism typically intended to reach all or a very large portion of the population regardless of their earnings or employment status. Objective- To provide enough to co